{"url_path":"/sec/mens/10-k/2026/item-9","section_key":"item-9","section_title":"Item 9 THE OFFER AND LISTING**","topic":"sec","document":{"doc_type":"20-F","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1954488/0001213900-26-057073-index.html","accession_number":"0001213900-26-057073","cik":"0001954488","ticker":"MENS","issuer_name":"Jyong Biotech Ltd.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1954488/0001213900-26-057073-index.html","primary_entity_key":"0001954488","primary_entity_name":"Jyong Biotech Ltd."},"word_count":74,"has_tables":true,"body_markdown":"**Item 9. THE OFFER AND LISTING**\n\n** **\n\n**A. Offer and Listing Details.**\n\n \n\nOur ordinary shares have been listed on the Nasdaq Global Market since\nJune 17, 2025 under the symbol “MENS.”\n\n \n\n**B. Plan of Distribution**\n\n \n\nNot applicable.\n\n \n\n**C. Markets**\n\n \n\nOur ordinary shares have been listed on the Nasdaq Global Market since\nJune 17, 2025 under the symbol “MENS.”\n\n \n\n**D. Selling Shareholders**\n\n \n\nNot applicable.\n\n \n\n**E. Dilution**\n\n \n\nNot applicable.\n\n \n\n146\n\n \n\n \n\n**F. Expenses of the Issue**\n\n \n\nNot\napplicable."}